Literature DB >> 32750119

Relationship between the ABO Blood Group and the COVID-19 Susceptibility.

Jiao Zhao1, Yan Yang2, Hanping Huang3, Dong Li4, Dongfeng Gu1, Xiangfeng Lu5, Zheng Zhang2, Lei Liu2, Ting Liu3, Yukun Liu6, Yunjiao He1, Bin Sun1, Meilan Wei1, Guangyu Yang7, Xinghuan Wang8, Li Zhang3, Xiaoyang Zhou4, Mingzhao Xing1, Peng George Wang1.   

Abstract

To explore any relationship between the ABO blood group and the COVID-19 susceptibility, we compared ABO blood group distributions in 2,173 COVID-19 patients with local control populations, and found that blood group A was associated with an increased risk of infection, whereas group O was associated with a decreased risk.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ABO blood group; COVID-19; SARS-CoV-2; coronavirus; disease

Year:  2020        PMID: 32750119      PMCID: PMC7454371          DOI: 10.1093/cid/ciaa1150

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  193 in total

Review 1.  The complement system in COVID-19: friend and foe?

Authors:  Anuja Java; Anthony J Apicelli; M Kathryn Liszewski; Ariella Coler-Reilly; John P Atkinson; Alfred Hj Kim; Hrishikesh S Kulkarni
Journal:  JCI Insight       Date:  2020-08-06

2.  How the pandemic might play out in 2021 and beyond.

Authors:  Megan Scudellari
Journal:  Nature       Date:  2020-08       Impact factor: 49.962

Review 3.  ABO blood group and COVID-19: an updated systematic literature review and meta-analysis.

Authors:  Massimo Franchini; Mario Cruciani; Carlo Mengoli; Giuseppe Marano; Fabio Candura; Nadia Lopez; Ilaria Pati; Simonetta Pupella; Vincenzo De Angelis
Journal:  Blood Transfus       Date:  2021-05-12       Impact factor: 3.443

4.  An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.

Authors:  Liuyang Wang; Thomas J Balmat; Alejandro L Antonia; Florica J Constantine; Ricardo Henao; Thomas W Burke; Andy Ingham; Micah T McClain; Ephraim L Tsalik; Emily R Ko; Geoffrey S Ginsburg; Mark R DeLong; Xiling Shen; Christopher W Woods; Elizabeth R Hauser; Dennis C Ko
Journal:  Genome Med       Date:  2021-05-17       Impact factor: 15.266

5.  Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach.

Authors:  Marie-Thérèse Hopp; Daniel Domingo-Fernández; Yojana Gadiya; Milena S Detzel; Regina Graf; Benjamin F Schmalohr; Alpha T Kodamullil; Diana Imhof; Martin Hofmann-Apitius
Journal:  Biomolecules       Date:  2021-04-27

6.  ABO in Correlation to the Requirement of Mechanical Ventilation and Mortality in Critically Ill Patients With COVID-19.

Authors:  Rehab Y Al-Ansari; Abdulaziz Alshaer; Aamer Al-Anazi; Nasser Al-Otaibi; Leena Abdalla; Sufana Al-Tarrah; Amal Shilash; Nada Al-Zahrani
Journal:  J Hematol       Date:  2021-04-27

Review 7.  COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.

Authors:  Jae C Chang
Journal:  Vasc Health Risk Manag       Date:  2021-06-01

Review 8.  SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models.

Authors:  G Kanimozhi; B Pradhapsingh; Charan Singh Pawar; Haseeb A Khan; Salman H Alrokayan; N Rajendra Prasad
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

9.  ABO blood type: a window into the genetics of acute respiratory distress syndrome susceptibility.

Authors:  Alicia N Rizzo; Eric P Schmidt
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

10.  Kidney Transplant Recipients Infected With Coronavirus Disease 2019: Retrospective Qatar Experience.

Authors:  Mohamad M Alkadi; Hassan A Al-Malki; Muhammad Asim; Omar M Fituri; Ahmed F Hamdi; Rihab I Elidrisi; Ramzi Abdul Rahiman; Mostafa F Elshirbeny; Muftah A Othman; Awais Nauman; Adel Ashour; Tarek A Ghonimi; Hiba Tohid; Mona E Jarman; Abdullah Hamad; Mohamed B Elshazly; Essa Abuhelaiqa
Journal:  Transplant Proc       Date:  2021-06-11       Impact factor: 1.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.